Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Peripheral Nervous System Diseases × N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Colorectal Neoplasms 2 Peripheral Nervous System Diseases 1 Neoplasm Metastasis 1

Interventions

Glutamine 2 glutamic acid diethyl ester 1 Sugars 1 Sodium Selenite 1 Sodium Chloride 1 Saline Solution 1 Paclitaxel 1 Omeprazole 1 N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1 Ketamine 1 Glutamic Acid 1 Drug Therapy 1 Carboplatin 1 Bevacizumab 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04034355 2022-01-26

POLAR-A

Egetis Therapeutics

Phase 3 Terminated

301 enrolled 18 charts

Gastrointestinal

Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡